Eculizumab Intravenous and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Eculizumab Intravenous and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: eculizumab
Brand name: Soliris
Synonyms: Eculizumab
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eculizumab Intravenous-Lithium ER
- Eculizumab Intravenous-Lithium Oral Solution
- Eculizumab Intravenous-Lithium Salts
- Eculizumab Intravenous-Lithium Syrup and Oral Solution
- Eculizumab Intravenous-Lithobid
- Eculizumab Intravenous-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Ed A-Hist
- Lithium Controlled-Release and Extended-Release Tablets-Ed A-Hist DM
- Lithium Controlled-Release and Extended-Release Tablets-Ed ChlorPed
- Lithium Controlled-Release and Extended-Release Tablets-Ed ChlorPed D
- Lithium Controlled-Release and Extended-Release Tablets-Ed Cyte F
- Lithium Controlled-Release and Extended-Release Tablets-Ed-Chlor Ped Jr